Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Zetia

FDA fails to approve cholesterol drug for kidney disease

U.S. health regulators amended the prescribing label for Merck & Co’s cholesterol-lowering drug Vytorin to show it prevents heart problems in patients with chronic kidney disease, but stopped short of approving its use for that purpose.

The decision means Merck cannot market Vytorin as a treatment for reducing the rate of heart problems in… FDA fails to approve cholesterol drug for kidney disease   



prostate tissue cells1 - anti-inflammatory drugs1 - childbirth2 - rapid kidney function decline1 - autosomal-dominant polycystic kidney disease2 - metanephros1 - urine test3 - chromosome defects1 - pregnancy complications1 - cardiovascular disease5 - menopause1 - urinary proteins2 - heart damage1 - hypercalcemia1 - kidney stone2 - klotho hormone1 - prostate cancer detection1 - rate of prostate cancer1 - seizure1 - sex after prostate surgery1 - prostate-specific antigen12 - diagnostic test2 - institute of cancer research1 - mortality risk1 - noninvasive imaging1 - bladder control loss1 - low blood pressure1 - the journal of urology2 - bony pelvis3 - gametogenesis2 -